JP2019506175A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019506175A5 JP2019506175A5 JP2018544819A JP2018544819A JP2019506175A5 JP 2019506175 A5 JP2019506175 A5 JP 2019506175A5 JP 2018544819 A JP2018544819 A JP 2018544819A JP 2018544819 A JP2018544819 A JP 2018544819A JP 2019506175 A5 JP2019506175 A5 JP 2019506175A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- signal peptide
- nucleic acid
- ige signal
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021189383A JP7555325B2 (ja) | 2016-02-25 | 2021-11-22 | ジカウイルスに対する新規のワクチン |
| JP2024073806A JP2024096281A (ja) | 2016-02-25 | 2024-04-30 | ジカウイルスに対する新規のワクチン |
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662300030P | 2016-02-25 | 2016-02-25 | |
| US62/300,030 | 2016-02-25 | ||
| US201662305183P | 2016-03-08 | 2016-03-08 | |
| US62/305,183 | 2016-03-08 | ||
| US201662396742P | 2016-09-19 | 2016-09-19 | |
| US62/396,742 | 2016-09-19 | ||
| US201662417100P | 2016-11-03 | 2016-11-03 | |
| US62/417,100 | 2016-11-03 | ||
| US201762462249P | 2017-02-22 | 2017-02-22 | |
| US62/462,249 | 2017-02-22 | ||
| PCT/US2017/019407 WO2017147458A1 (en) | 2016-02-25 | 2017-02-24 | Novel vaccines against zika virus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021189383A Division JP7555325B2 (ja) | 2016-02-25 | 2021-11-22 | ジカウイルスに対する新規のワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019506175A JP2019506175A (ja) | 2019-03-07 |
| JP2019506175A5 true JP2019506175A5 (enExample) | 2020-04-02 |
| JP7012365B2 JP7012365B2 (ja) | 2022-03-04 |
Family
ID=59685658
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018544819A Active JP7012365B2 (ja) | 2016-02-25 | 2017-02-24 | ジカウイルスに対する新規のワクチン |
| JP2021189383A Active JP7555325B2 (ja) | 2016-02-25 | 2021-11-22 | ジカウイルスに対する新規のワクチン |
| JP2024073806A Pending JP2024096281A (ja) | 2016-02-25 | 2024-04-30 | ジカウイルスに対する新規のワクチン |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021189383A Active JP7555325B2 (ja) | 2016-02-25 | 2021-11-22 | ジカウイルスに対する新規のワクチン |
| JP2024073806A Pending JP2024096281A (ja) | 2016-02-25 | 2024-04-30 | ジカウイルスに対する新規のワクチン |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11648303B2 (enExample) |
| EP (1) | EP3419660A4 (enExample) |
| JP (3) | JP7012365B2 (enExample) |
| KR (1) | KR20190003471A (enExample) |
| CN (2) | CN109152826B (enExample) |
| AU (3) | AU2017222644B2 (enExample) |
| BR (1) | BR112018017307A2 (enExample) |
| CA (1) | CA3015792A1 (enExample) |
| MX (2) | MX2018010291A (enExample) |
| WO (1) | WO2017147458A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4218805A1 (en) | 2015-07-21 | 2023-08-02 | ModernaTX, Inc. | Infectious disease vaccines |
| US11364292B2 (en) | 2015-07-21 | 2022-06-21 | Modernatx, Inc. | CHIKV RNA vaccines |
| EP3364950A4 (en) | 2015-10-22 | 2019-10-23 | ModernaTX, Inc. | VACCINES AGAINST TROPICAL DISEASES |
| AU2017222644B2 (en) | 2016-02-25 | 2021-07-29 | The Trustees Of The University Of Pennsylvania | Novel vaccines against Zika virus |
| US11666649B2 (en) * | 2016-10-11 | 2023-06-06 | University Of Miami | Vectors and vaccine cells for immunity against Zika virus |
| US11806393B2 (en) * | 2017-02-10 | 2023-11-07 | La Jolla Institute For Allergy And Immunology | Flavivirus peptide sequences, epitopes, and methods and uses thereof |
| WO2018151816A1 (en) | 2017-02-16 | 2018-08-23 | Modernatx, Inc. | High potency immunogenic compositions |
| MA50253A (fr) | 2017-09-14 | 2020-07-22 | Modernatx Inc | Vaccins à arn contre le virus zika |
| CA3081581A1 (en) | 2017-11-03 | 2019-05-09 | Takeda Vaccines, Inc. | Method for inactivating zika virus and for determining the completeness of inactivation |
| AU2018375173B2 (en) | 2017-11-30 | 2022-08-25 | Takeda Vaccines, Inc. | Zika vaccines and immunogenic compositions, and methods of using the same |
| WO2019113285A2 (en) * | 2017-12-06 | 2019-06-13 | Emory University | Zika vaccines and methods of use |
| EP3826672A4 (en) | 2018-07-23 | 2022-04-20 | The University of Adelaide | VACCINE AGAINST THE ZIKA VIRUS |
| BR112021008217A2 (pt) * | 2018-10-31 | 2021-08-17 | Icahn School Of Medicine At Mount Sinai | anticorpos humanos que têm como alvo vírus zika ns1, polipeptídeos ns1 e seus usos |
| US12070495B2 (en) | 2019-03-15 | 2024-08-27 | Modernatx, Inc. | HIV RNA vaccines |
| EP4306641A4 (en) * | 2021-02-05 | 2025-06-04 | ST Pharm Co., Ltd. | NEW NUCLEIC ACID MOLECULE |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1108036B1 (en) * | 1998-09-02 | 2010-06-23 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Dengue viruses that are replication defective in mosquitos for use as vaccines |
| EP2026839A4 (en) * | 2005-12-14 | 2009-04-01 | Univ Oklahoma | RNA VIRUS VACCINE AND METHODS |
| US8835620B2 (en) | 2008-01-11 | 2014-09-16 | Vgx Pharmaceuticals, Llc | Vaccines against multiple subtypes of dengue virus |
| CA2740598C (en) | 2008-11-17 | 2018-05-22 | Mathura P. Ramanathan | Antigens that elicit immune response against flavivirus and methods of using same |
| WO2011032179A1 (en) * | 2009-09-14 | 2011-03-17 | The Trustees Of The University Of Pennsylvania | Vaccines and immunotherapeutics comprising il-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same |
| JP2013509203A (ja) | 2009-11-02 | 2013-03-14 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 口蹄疫ウイルス（ｆｍｄｖ）コンセンサスタンパク質、そのコード配列およびそれから生成されるワクチン |
| US8691961B1 (en) * | 2009-11-09 | 2014-04-08 | Integral Molecular, Inc. | Flavivirus reporter virus and methods of making and using the same |
| WO2011115583A1 (en) | 2010-03-19 | 2011-09-22 | National University Of Singapore | A novel platform for retrovirus-like particle (vlp)-display of vaccine antigens |
| EP2550292B1 (en) | 2010-03-24 | 2017-11-22 | Research Development Foundation | Flavivirus host range mutations and uses thereof |
| BR112013014457A8 (pt) * | 2010-12-09 | 2017-12-19 | Pasteur Institut | usos da enzima 6-metilguanina-dna-metiltrasferase (mgmt, ec 2.1.1.63) para aumentar a produção de proteína heteróloga, bem como vetor de expressão, células recombinantes e polipeptídeo de fusão compreendendo sinal de secreção peptídica e proteína snap |
| WO2012106377A2 (en) * | 2011-01-31 | 2012-08-09 | The Trustees Of The University Of Pennsylvania | Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof |
| ES2648899T3 (es) | 2011-12-09 | 2018-01-08 | Institut Pasteur | Inmunoensayo de cribado múltiplex |
| WO2014144786A1 (en) * | 2013-03-15 | 2014-09-18 | The Trustees Of The University Of Pennsylvania | Novel vaccines against multiple subtypes of dengue virus |
| MY187459A (en) * | 2015-07-16 | 2021-09-23 | Bharat Biotech Int Ltd | Vaccine compositions |
| EP4218805A1 (en) * | 2015-07-21 | 2023-08-02 | ModernaTX, Inc. | Infectious disease vaccines |
| EP3364950A4 (en) * | 2015-10-22 | 2019-10-23 | ModernaTX, Inc. | VACCINES AGAINST TROPICAL DISEASES |
| SG11201806340YA (en) * | 2016-02-17 | 2018-09-27 | Curevac Ag | Zika virus vaccine |
| AU2017222644B2 (en) * | 2016-02-25 | 2021-07-29 | The Trustees Of The University Of Pennsylvania | Novel vaccines against Zika virus |
| AU2017298576B2 (en) * | 2016-07-18 | 2023-04-13 | Variation Biotechnologies Inc. | Vaccine compositions for treatment of Zika virus |
| JP2019533993A (ja) * | 2016-09-19 | 2019-11-28 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | ジカウイルスに対する新規ワクチンとジカウイルスに対する使用に向けたｄｎａ抗体構築物との組み合わせ |
| US11241490B2 (en) * | 2017-01-11 | 2022-02-08 | The Trustees Of The University Of Pennsylvania | Nucleoside-modified RNA for inducing an immune response against zika virus |
| EP3412307A1 (en) * | 2017-06-07 | 2018-12-12 | Institut Pasteur | Recombinant measles virus expressing zika virus proteins and their applications |
-
2017
- 2017-02-24 AU AU2017222644A patent/AU2017222644B2/en active Active
- 2017-02-24 CA CA3015792A patent/CA3015792A1/en active Pending
- 2017-02-24 CN CN201780017976.1A patent/CN109152826B/zh active Active
- 2017-02-24 CN CN202211273088.5A patent/CN115927399A/zh active Pending
- 2017-02-24 WO PCT/US2017/019407 patent/WO2017147458A1/en not_active Ceased
- 2017-02-24 EP EP17757325.0A patent/EP3419660A4/en active Pending
- 2017-02-24 BR BR112018017307A patent/BR112018017307A2/pt unknown
- 2017-02-24 KR KR1020187027172A patent/KR20190003471A/ko active Pending
- 2017-02-24 MX MX2018010291A patent/MX2018010291A/es unknown
- 2017-02-24 US US16/078,270 patent/US11648303B2/en active Active
- 2017-02-24 JP JP2018544819A patent/JP7012365B2/ja active Active
-
2018
- 2018-08-24 MX MX2023006203A patent/MX2023006203A/es unknown
-
2021
- 2021-10-29 AU AU2021258056A patent/AU2021258056B2/en active Active
- 2021-11-22 JP JP2021189383A patent/JP7555325B2/ja active Active
-
2023
- 2023-05-16 US US18/318,061 patent/US12419945B2/en active Active
-
2024
- 2024-04-30 JP JP2024073806A patent/JP2024096281A/ja active Pending
- 2024-07-04 AU AU2024204641A patent/AU2024204641A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019506175A5 (enExample) | ||
| Zens et al. | Memory CD4 T cells in influenza | |
| US12239699B2 (en) | Immunogen for broad-spectrum influenza vaccine and application thereof | |
| JP2015501656A5 (enExample) | ||
| JP6333730B2 (ja) | 改善されたｉｌ−１２遺伝子構築物を含む組成物、及びそれを用いたワクチン、免疫治療剤及び方法 | |
| JP2014534202A5 (enExample) | ||
| JP2012515557A5 (enExample) | ||
| RU2677799C2 (ru) | Модифицированные суперспиральные белки с улучшенными свойствами | |
| FI3872085T3 (fi) | Esimuotoiset virussekvenssit ja niiden käytöt | |
| JP2014507146A5 (enExample) | ||
| JP2010516290A5 (enExample) | ||
| JP2009540801A5 (enExample) | ||
| JP2015501840A5 (enExample) | ||
| JP2013507907A5 (enExample) | ||
| JP2013515747A5 (enExample) | ||
| JP2016517414A (ja) | インフルエンザ核酸分子及びそれから作製したワクチン | |
| JP2006514549A5 (enExample) | ||
| CN112852848B (zh) | 一种含密码子优化的结核分枝杆菌融合蛋白ah疫苗 | |
| WO2022071513A1 (ja) | ＳＡＲＳ－ＣｏＶ－２に対する改良型ＤＮＡワクチン | |
| CN103467571A (zh) | 一种畜禽免疫增强剂法氏囊多肽 | |
| KR20180064158A (ko) | 구제역 바이러스의 가용성 다가 항원단백질 및 이의 용도 | |
| CN103173455B (zh) | 一种具有抗新城疫病毒活性的鹅源基因rig-i及其应用 | |
| JP2013504600A5 (enExample) | ||
| CN106282178A (zh) | 重组嗜酸乳杆菌s层蛋白在大肠杆菌中的高效表达及其应用 | |
| JP2013545735A (ja) | インフルエンザウィルスの組換えヘマグルチニン蛋白質及びそれを含むワクチン |